JAK Inhibition in a Patient with X-Linked Reticulate Pigmentary Disorder

J Clin Immunol. 2021 Jan;41(1):212-216. doi: 10.1007/s10875-020-00867-7. Epub 2020 Sep 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Biomarkers
  • DNA Polymerase I / genetics
  • Disease Management
  • Genes, X-Linked*
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Humans
  • Immunohistochemistry
  • Infant
  • Janus Kinase Inhibitors / therapeutic use*
  • Male
  • Mutation
  • Pigmentation Disorders / diagnosis
  • Pigmentation Disorders / drug therapy*
  • Pigmentation Disorders / etiology*
  • Symptom Assessment
  • Treatment Outcome

Substances

  • Biomarkers
  • Janus Kinase Inhibitors
  • DNA Polymerase I